Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000466077 | SCV000563822 | uncertain significance | Multiple endocrine neoplasia, type 2 | 2016-11-23 | criteria provided, single submitter | clinical testing | This variant is a gross deletion of the genomic region encompassing exons 2-3 of the RET gene. This leads to an in-frame deletion, preserving the integrity of the reading frame. Gross deletion of exons 2-3 has not been reported in the literature in individuals with a RET-related disease. Experimental studies and prediction algorithms are not available for this variant, and the functional significance of the deleted amino acid is currently unknown. In summary, this variant is a novel in-frame deletion with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. |